Ardelyx Selected as a Finalist in the Fierce Innovation Awards for the Development of its First-in-Class Product Candidate TenapanorPRNewsWire • 08/03/20
Ardelyx Appoints Veteran Biopharma Executive, Justin Renz, as Chief Financial OfficerPRNewsWire • 06/08/20
Ardelyx Strengthens Management Team with Appointment of Susan Rodriguez as Chief Commercial OfficerPRNewsWire • 05/18/20
Ardelyx's Tenapanor Is A Long-Needed Alternative For A Cardiorenal Disease ComplicationSeeking Alpha • 11/11/19